ID   NCC-CC4-2
AC   CVCL_A8DR
DR   TKG; TKG 0746
DR   Wikidata; Q107116523
RX   PubMed=26141945;
RX   PubMed=27833395;
CC   Population: Japanese.
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
ST   Source(s): TKG=TKG 0746
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 10,13
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7888 ! NCC-CC4-1
OI   CVCL_A8DS ! NCC-CC4-3
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 02-05-24; Version: 5
//
RX   PubMed=26141945; DOI=10.1158/1535-7163.MCT-15-0069;
RA   Shirota T., Ojima H., Hiraoka N., Shimada K., Rokutan H., Arai Y.,
RA   Kanai Y., Miyagawa S., Shibata T.;
RT   "Heat shock protein 90 is a potential therapeutic target in
RT   cholangiocarcinoma.";
RL   Mol. Cancer Ther. 14:1985-1993(2015).
//
RX   PubMed=27833395; DOI=10.3748/wjg.v22.i40.9035; PMCID=PMC5083809;
RA   Ojima H., Yamagishi S., Shimada K., Shibata T.;
RT   "Establishment of various biliary tract carcinoma cell lines and
RT   xenograft models for appropriate preclinical studies.";
RL   World J. Gastroenterol. 22:9035-9038(2016).
//